SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation
Ryan A. Denu(The University of Texas MD Anderson Cancer Center)
Cited by 75
Related Papers
ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0